ZEISS announces it will be highlighting a wide range of precision microscopes, imaging solutions, and software at M&M 2015, the Microscopy & Microanalysis 2015 Meeting, which will be held August 2-6, 2015 at the Oregon Convention Center in Portland, Oregon.
On display at Booth #638 will be the ZEISS GeminiSEM field emission scanning electron microscope (FE-SEM), ZEISS Atlas 5 Array Tomography, and Airyscan, which pushes sensitivity beyond the limits of all conventional confocals.
Stop by to see the ZEISS GeminiSEM field emission scanning electron microscope, the ideal field emission SEM for high contrast, low voltage images. Image effortlessly with sub-nanometer resolution and high detection efficiency, even at higher pressures. GeminiSEM 500 comes with a novel Gemini optical design to deliver better resolution, especially at low voltage.
Also on display is Atlas 5 Array Tomography, a unique, easy-to-use hardware and software package for your electron microscope that uses advanced Atlas functionalities and a workflow oriented user interface to guide users through all imaging tasks. Specifically designed for automated imaging necessary in an array tomography workflow, Atlas 5 Array Tomography can help image thousands of serial sections of biological tissue automatically to enable 3D EM.
To learn how to revolutionize your confocal imaging, take a look at ZEISS Airyscan, which features a new detection concept that uses an array detector to oversample each Airy disk to gain sensitivity, resolution and speed for higher throughput. Unlike other superresolution techniques, Airyscan capitalizes on the scanning and optical sectioning capabilities of a confocal, capable of working with thicker samples that need a higher penetration depth.
Join us in our booth to discover new insights to your real world questions. Lunch and learn sessions and evening tutorials by our microscopy experts will offer the newest advances in confocal and field emission technology and demonstrate the next level of correlating microscopes in multiple dimensions.
Lunch and learn sessions:
- Monday, August 3rd – 12:00-1:00 pm – GeminiSEM 500: More Detail, More Signal, More Flexibility
- Tuesday, August 4th – 12:00-1:00 pm – Revolutionize Your Confocal Imaging with ZEISS Airyscan
- Wednesday, August 5th – 12:00-1:00 pm – Introduction to the new ZEISS Sigma Family
Evening tutorials:
- Tuesday, August 4th – 5:45-6:45 pm – 3D Characterization and Correlation in Material Science
- Wednesday, August 5th – 5:45-6:15 pm – Advances in 3D and Correlative Scanning Electron Microscopy
- Wednesday, August 5th – 6:15-6:45 pm – 6:45 PM – High-Throughput SEM via Multi-Beam SEM
About ZEISS
ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. ZEISS develops and distributes lithography optics, measuring technology, microscopes, medical technology, eyeglass lenses, camera and cine lenses, binoculars and planetarium technology. With its solutions, the company constantly advances the world of optics and helps shape technological progress. The company is divided up into the six business groups Industrial Metrology, Microscopy, Medical Technology, Vision Care, Consumer Optics and Semiconductor Manufacturing Technology. ZEISS is represented in over 40 countries – with around 30 production sites, over 50 sales and service locations and about 25 research and development facilities. In fiscal year 2013/14 the company generated revenue approximating 4.3 billion euros with just under 25,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).
Further information at www.zeiss.com
Microscopy
The Microscopy business group is the world's only one-stop manufacturer of light, X-ray and electron microscope systems. The portfolio includes solutions and services both for life sciences and materials research and for industry, education and clinical practice. The business group is headquartered in Jena. Additional production and development sites are located in Oberkochen, Göttingen and Munich in Germany, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. The business group employs a total of over 3,000 people. It generated revenue of 656 million euros in fiscal year 2013/14.